Grant: CIHR Café Scientifique Program

Approximately 500,000 Canadians suffer from dementia and this expected to increase to over a million by 2035. The role of medications in the treatment of dementia is controversial and confusing for physicians and for the public. Cognitive enhancing medications are prescribed to 50% of people with dementia but many questions remain about their effectiveness and optimal use. The role of medications to treat the behavioural and psychiatric symptoms of dementia is also controversial as Health Canada has issued warnings about the use of antipsychotic medication for this condition. In addition, many medications used for treatment of common health conditions can worsen memory and cognition and increase symptoms of dementia. This Cafe Scientifique will apply the most up-to-date research and the clinical experience of the presenters to help participants to minimize the risks of medications and to ensure the most appropriate use of medications to treat symptoms of dementia. The Cafe will be relevant for persons with dementia, their caregivers and for health providers.